Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion

Onkologie

Volumn 26, Issue 1, 2003, Pages 63-65

  Thuss Patience, P C ^b   Kretzschmar, A ^b   Krenn, V ^a   Dorken B ^b   Reichardt, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Med Klin Schwerpunkt Hamatologie ^*

Author keywords

Chemotherapy; Docetaxel; Gastric cancer; Metastasis

Indexed keywords

CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

ABDOMINAL MASS; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; METASTASIS; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SPLEEN INJURY; STOMACH ADENOCARCINOMA; STOMATITIS; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; SPLEEN; SPLENIC NEOPLASMS; STOMACH NEOPLASMS; TAXOIDS; TREATMENT OUTCOME;

EID: 0037221922     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069866     Document Type: Article

References (14)

1. Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H: A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 1994;5:609-616.
2. Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A, Meehan M: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997;15:261-267.
3. Taguchi T for the Cooperative Group of Docetaxel for Gastric Cancer in Japan: A late phase II study of docetaxel in patients with gastric cancer. Proc ASCO 1997;16:263a.
4. Mavroudis D, Kourousis CH, Androulakis N, Kalbakis K, Agelaki S, Kakolyris S, Souglakos J, Sarra E, Vardakis N, Hatzidaki D, Sarmonis G, Georgoulias V: Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF). Am J Clin Oncol 2000;23: 341-344.
5. Sulkes A, Smyth J, Sessa C, Dirix LY, Vermorken JB, Kaye S, Wanders J, Franklin H, LeBail N, Verweij J: Docetaxel (Taxotere) in advanced gastric cancer: Results of a phase II clinical trial. EORTC Early Clinical Trials Group. Br J Cancer 1994;70: 380-383.
6. Einzig AI, Neuberg D, Remick SC, Karp DD, O'Dwyer PJ, Stewart JA, Benson AB 3rd: Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Med Oncol 1996;13:87-93.
7. Burris HA: Docetaxel in combination with fluorouracil for advanced solid tumors. Oncology 1997;11(suppl 8):50-52.
8. Vanhoefer U, Wilke H, Harstrick A, Achterrath W, Preusser P, Stahl M, Clemens MR, Thiel E, Flasshove M, Fink U, Trenn G, Seeber S: Phase II study of Docetaxel as second line chemotherapy in metastatic gastric cancer. Proc ASCO 1999;18:303a.
9. Meta-Analysis Group in Cancer: Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998;16:301-308.
10. Tubiana-Mathieu N, Merrouche Y, Cupissol D, Calais G, Bourgeois H, Filipi MH, Saliba E, Assadourian S: A phase II study of docetaxel (Taxotere®) in metastatic or recurrent squamous cell carcinoma of the head and neck. Proc ASCO 1998;17:412a.
11. Constela M, Garcia-Arroyo FR, Lorenzo I, Carrete N, Rey C: A phase II study of Docetaxel with weekly high-dose 5-FU and leucovorin (24-hour infusion) in advanced gastric cancer. Proc ASCO 1998;17: 289a.
12. Chun HG, Puccio CA, Mittelman A: Weekly docetaxel and continuous infusion 5-Fluorouracil in elderly patients with cancer of the stomach and distal esophagus. Proc ASCO 2001;20:162a.
13. Ross P, Cunningham D, Scarffe H, Nicolson M, Seymour M, Harper P, Price T, Hill A, Anderson H, Iveson T, Hickisl T, Lofts F, Norman A: Results of a randomised trial comparing ECF with MCF in advanced oesophagogastric cancer. Proc ASCO 1999;18:272a.
14. Thuss-Patience PC, Kretzschmar A, Vielhaber A, Repp M, Löschner C, Junkers R, Hennesser D, Michel S, Dörken B, Reichardt P: Docetaxel and 5-FU continuous infusion versus epirubicin, cisplatin and 5-FU for advanced gastric adenocarcinoma: A randomized phase II study. Proc ASCO 2002;21: 162a.